title: Cutaneous side-effects of antihepatitis C treatment: the U.K. experience.
authors: Department of Dermatology, King's College Hospital, Denmark Hill, London, SE5 9RS, U.K. elizabethjorrin@gmail.com.
authors: E
authors: E
authors: Orrin
authors: A
authors: A
authors: Barnabas
authors: K
authors: K
authors: Agarwal
authors: S A
authors: SA
authors: Walsh
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects*; D011392:Proline / Q000009:adverse effects / Q000031:analogs & derivatives*; D011480:Protease Inhibitors / Q000009:adverse effects*; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline